[HTML][HTML] International psychometric validation of the Chronic Venous Disease quality of life Questionnaire (CIVIQ-20)

R Launois, A Mansilha, G Jantet - European Journal of Vascular and …, 2010 - Elsevier
OBJECTIVE: To review the psychometric validation of the Chronic Venous dIsease quality
of life Questionnaire (CIVIQ-20) in the countries that have used it since 1996. DESIGN: …

Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum

…, S Kakkos, R Launois… - … : a journal of the …, 2016 - pubmed.ncbi.nlm.nih.gov
… 1 , Bo Eklof, Andre VAN Rij, Nicos Labropoulos, Michael Vasquez, Andrew Nicolaides,
Werner Blattler, Didier Bouhassira, Eliete Bouskela, Patrick Carpentier, Katy Darvall …

[HTML][HTML] Health-related quality-of-life scales specific for chronic venous disorders of the lower limbs

R Launois - Journal of Vascular Surgery: Venous and Lymphatic …, 2015 - Elsevier
Objective We conducted a systematic review of the literature about quality-of-life (QOL)
scales in chronic venous disorders (CVDs) comprising leg ulcers to identify the respective …

[PDF][PDF] A specific quality of life scale in upper limb lymphedema: the ULL-27 questionnaire

R Launois, AC Megnigbeto, K Pocquet, F Alliot… - …, 2002 - researchgate.net
There are 34,000 new cases of breast cancer each year in France. Recent studies have
confirmed that upper limb lymphœdema secondary to radio-chemo-surgical treatment develops …

An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and …

…, P Schöffski, K Hieke, L Mantovani, R Launois… - Value in …, 2008 - Wiley Online Library
Objectives: A phase III randomized trial that compared the combination of cetuximab and
radiotherapy to radiotherapy alone in patients with locally advanced squamous cell carcinoma …

A cost-utility analysis of second-line chemotherapy in metastatic breast cancer: docetaxel versus paclitaxel versus vinorelbine

R Launois, J Reboul-Marty, B Henry, J Bonneterre - Pharmacoeconomics, 1996 - Springer
The aim of this study was to determine the incremental effectiveness, the incremental health-related
quality of life (differences in quality-adjusted progression-free survival between …

Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian metaanalysis

R Launois, B Avouac, F Berenbaum, O Blin… - The Journal of …, 2011 - jrheum.org
Objective. To compare the clinical efficacy of certolizumab pegol (CZP) with that of other
anticytokine agents indicated for the treatment of rheumatoid arthritis (RA) with identical …

Systematic review and bivariate/HSROC random-effect meta-analysis of immunochemical and guaiac-based fecal occult blood tests for colorectal cancer screening

R Launois, JG Le Moine, B Uzzan… - European journal of …, 2014 - journals.lww.com
Background Current literature evidences higher accuracy of immunological (iFOBT) vis-à-vis
guaiac-based (gFOBT) fecal occult blood tests for colorectal cancer (CRC) screening. Few …

[PDF][PDF] The European Evaluation of Vertigo scale (EEV): a clinical validation study

…, JP Sauvage, R Launois - Revue de Laryngologie …, 2001 - rees-france.com
The European Evaluation of Vertigo scale (EEV) is a physician-administered questionnaire
that only assesses symptoms and allows physicians to quantitatively evaluate vertigo, along …

Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis

C Hassan, DK Rex, GS Cooper, A Zullo, R Launois… - Gut, 2012 - gut.bmj.com
Objective Low-dose aspirin reduces colorectal cancer (CRC) incidence and mortality. Recently,
the aspirin effect has been shown to occur primarily in the proximal colon. Colonoscopy …